Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
SUSS MicroTec SE is a German mechanical engineering company specializing in the development, manufacture, marketing, and maintenance of precision systems for microstructuring in the semiconductor industry. Founded in 1949 and headquartered in Garching bei München, it pioneered the world's first mask aligner in 1963, evolving from optical instrument distribution to a global leader in backend lithography, wafer bonding, and photomask processing. The company operates through two core divisions: Advanced Backend Solutions, offering mask aligners, coaters, developers, UV projection scanners, and temporary/permanent bonders essential for advanced packaging, MEMS, compound semiconductors, LEDs, and 3D integration; and Photomask Solutions, providing specialized cleaning and processing equipment for semiconductor photomasks. Serving high-volume production and R&D institutions worldwide, SUSS MicroTec supports key applications in AI chips, high-bandwidth memory, consumer electronics, automotive, medical technology, and aerospace. With over 8,000 installed systems, production sites in Germany and Taiwan, and a strong Asia-Pacific focus, it drives innovation through strategic expansions and a commitment to high yield, throughput, and cost efficiency in microelectronics manufacturing.
12.01% operating margin is respectable but not wide. ROIC at 13.82%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 12.8%, still solid. Margins contracted 5.1pp, which offsets some of the top-line progress.
Free cash flow declined 187% versus the prior year, cash generation momentum has weakened. ROIC dropped from 17.37% to 13.82%, capital efficiency is deteriorating.
Profitability & Returns
Revenue (FY)
€503M
▲ +12.8% YoY
Net Income (FY)
€46M
▼ -58.2% YoY
Op. Margin
12.01%
▼ -5.1pp YoY
ROIC
13.82%
▼ -3.5pp YoY
Cash Flow & Balance Sheet
FCF (FY)
-€23M
▼ -187.1% YoY
Op. Cash Flow (FY)
-€2M
▼ -105.6% YoY
Net Debt
-€49M
Net Cash Position
Cash & Equiv.
€99M
3Y CAGR: +24.1%
Continue Research